Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

mibe pharma italia s.r.l. - calcipotriolo, associazioni - calcipotriolo, associazioni

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum - crema - betamethasonum 0,5 mg per betamethasoni dipropionas, conserv.: chlorocresolum, excipiens annuncio unguento per 1 g. - non infetto dermatosi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum, gentamicinum - crema - betamethasonum 0.5 mg ut betamethasoni dipropionas, gentamicinum 1.0 mg ut gentamicini sulfas, natrii dihydrogenophosphas dihydricus, acidum phosphoricum, paraffinum liquidum, alcohol cetylicus et stearylicus 72 mg, macrogoli aether cetostearylicus, vaselinum album, natrii hydroxidum, aqua purificata, chlorocresolum 1 mg ad emulsionem pro 1 g. - infiammatoria secondaria batterico infetti dermatosi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum, gentamicinum - salve - betamethasonum 0.5 mg ut betamethasoni dipropionas, gentamicinum 1.0 mg ut gentamicini sulfas, paraffinum liquidum, vaselinum album, ad unguentum pro 1 g. - infiammatoria secondaria batterico infetti dermatosi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

organon gmbh - betamethasonum, clotrimazolum, gentamicinum - creme - betamethasonum 0.5 mg ut betamethasoni dipropionas, clotrimazolum 10 mg, gentamicinum 1 mg ut gentamicini sulfas, paraffinum liquidum, vaselinum album, alcohol cetylicus et stearylicus 72 mg, propylenglycolum 100 mg, macrogoli aether cetostearylicus, alcohol benzylicus 10 mg, natrii dihydrogenophosphas dihydricus, acidum phosphoricum concentratum, natrii hydroxidum, aqua purificata ad unguentum pro 1 g. - infiammatoria secondaria batterico e/o mykotisch infetti dermatosi - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - asma - farmaci per le malattie respiratorie ostruttive, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - calcipotriolum, betamethasonum - salve - calcipotriolum 0.05 mg ut calcipotriolum monohydricum, betamethasonum 0.5 mg ut betamethasoni dipropionas, paraffinum liquidum, polyoxypropyleni 11 aether stearylicus, e 307, e 321 0.05 mg, vaselinum album, ad unguentum pro 1 g. - la psoriasi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - calcipotriolum, betamethasonum - gel - calcipotriolum 50 µg ut calcipotriolum monohydricum, betamethasonum 0.5 mg ut betamethasoni dipropionas, paraffinum liquidum, polyoxypropyleni 11 aether stearylicus, ricini oleum hydrogenatum, e 307, e 321 160 µg, ad gelatum pro 1 g. - la psoriasi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

leo pharmaceutical products sarath ltd. - calcipotriolum, betamethasonum - gel - calcipotriolum 50 µg ut calcipotriolum monohydricum, betamethasonum 0.5 mg ut betamethasoni dipropionas, paraffinum liquidum, polyoxypropyleni 11 aether stearylicus, ricini oleum hydrogenatum, e 307, e 321 160 µg, ad gelatum pro 1 g. - la psoriasi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - calcipotriolum, betamethasonum - salve - calcipotriolum 50 µg, betamethasonum 0.5 mg ut betamethasoni dipropionas, paraffinum liquidum, polyoxypropyleni 15 aether stearylicus, vaselinum album, e 321 50 µg, ad unguentum pro 1 g. - la psoriasi - synthetika